参考文献/References:
[1] Khosroshahi A,Stone JH.A clinical overview of IgG4-related sys-temic disease[J].Curr Opin Rheumatol,2011,23(1):57-66.
[2] Hamano H,Kawa S,Horiuchi A,et al.High serum IgG4 concentra-tions in patients with sclerosing pancreatitis[J].N Engl J Med,2001,344(10):732-738.
[3] Hamano H,Kawa S,Ochi Y,et al.Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis[J].Lancet,2002,359(9315):1403-1404.
[4] Yamamoto M,Ohara M,Suzuki C,et al.Elevated IgG4 concentra-tions in serum of patients with Mikulicz’s disease[J].Scand J Rheumatol,2004,33(6):432-433.
[5] Takahashi H,Yamamoto M,Suzuki CA,et al.The birthday of a new syndrome:IgG4-related diseases constitute a clinical entity[J].Autoimmun Rev,2010,9(9):591-594.
[6] Hirabayashi K,Zamboni G.IgG4-related disease[J].Pathologica,2012,104(2):43-55.
[7] Umehara H,Okazaki K,Masaki Y,et al.Comprehensive diagnostic criteria for IgG4-related disease(IgG4-RD),2011[J].Mod Rheumatol,2012,22(1):21-30.
[8] Takahashi H,Yamashita H,Morooka MA,et al.The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-Related disease[J].Joint Bone Spine,2014,81(4):331-336.
[9] Ebbo M,Grados A,Guedj E,etal.Usefulness of 2-18F-fluoro-2-de-oxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease:a retrospective multicenter study[J].Arthritis Care Res(Hoboken),2014,66(1):86-96.
[10] Mahajan VS,Mattoo H,Deshpande V,et al.IgG4-Related disease[J].Annu Rev Pathol,2014,9:315-347.
[11] Proctor RD,Rofe CJ,Bryant T,et al.Autoimmune pancreatitis:An illustrated guide to diagnosis[J].Clin Radiol,2013,68(4):422-432.
[12] Santhosh S,Mittal BR,Bhasin DA,et al.Role of 18F-fluorodeoxyglu-Cose positron emission tomography/computed tomography in the characterization of pancreatic masses:Experience from tropics[J].J Gastroenterol Hepatol,2013,28(2):255-261.
[13] Nakajo M,Jinnouchi S,Fukukura YA,et al.The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associa-ted extrapancreatic autoimmune lesions[J].Eur J Nucl Med Mol Imaging,2007,34(12):2088-2095.
[14] Zhang J,Chen H,Ma Y,et al.Characterizing IgG4-related disease With 18F-FDGPET/CT:a prospective cohort study[J].Eur J Nucl Med MolImaging,2014,41(8):1624-1634.
[15] Stone JH,Khosroshahi A,Deshpande V,et al.Recommendations for the nomenclature of IgG4-related disease and its individual or-gan system manifestations[J].Arthritis Rheum,2012,64(10):3061-3067.
[16] Research Committee to establish diagnostic criteria and develop-ment of treatment for systemic IgG4-related sclerosing disease: Re-search Committee to establish a new clinical entity,IgG4-related multi-organ lymphoproliferative syndrome(IgG4-MOLPS).Com-prehensive diagnostic criteria for IgG4-related disease(IgG4-RD),2011.Research Program of Intractable Disease provided by the Ministry of Health,Labor,and Welfare of Japan[J].Nihon Naika Gakkai Zasshi.2012,101(3):795-804.
[17] Takuma K,Kamisawa T,Gopalakrishna R,et al.Strategy to differen-tiate autoimmune pancreatitis from pancreas cancer[J].World J Gastroenterol,2012,18(10):1015-1020.
[18] Nakatani K,Nakamoto Y,Togashi K.Utility of FDGPET/CT in IgG4-related systemic disease[J].Clin Radiol,2012,67(4):297-305.
[19] Matsumoto I,Shinzeki M,Toyama H,et al.A focal mass-forming autoimmune pancreatitis mimicking pancreatic cancer with ob-struction of themainpancreatic duct[J].J Gastrointest Surg,2011,15(12):2296-2298.
[20] Himi T,Takano K,Yamamoto M,et al.A novel concept of Mikulicz’s disease as IgG4-related disease[J].Auris Nasus Lar-ynx,2012,39(1):9-17.
[21] Yao Q,Wu G,Hoschar A.IgG4-related Mikulicz’sdisease is a multi-organ lymphoproliferative disease distinct from Sjogren’s syndrome:a Caucasian patient and literaturere view[J].Clin Exp Rheumatol,2013,31(2):289-294.
[22] Ketwaroo GA,Sheth S.Autoimmune pancreatitis[J].Gastroenterol rep(Oxf),2013,1(1):27-32.
[23] Imdah A,Nitzsche E,Krautmann F,et al.Evaluation of positron e-mission tomography with 2-[18F] fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer[J].Br J Surg,1999,86(2):194-199.
[24] Ozaki Y,Oguchi K,Hamano H,et al.Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluo-rodeoxyglucose positron emission tomography[J].J Gastroenterol,2008,43(2):144-151.
[25] Kawamura E,Habu D,Higashiyama SA,et al.A case of sclerosing cholangitis with autoimmune pancreatitis evaluated by FDG-PET[J].Ann Nucl Med,2007,21(4):223-228.
[26] Sato M,Okumura T,Shioyama Y,et al.Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis[J].Ann Nucl Med,2008,22(3):215-219.
[27] Suga K,Kawakami Y,Hiyama A,et al.F-18 FDG PET-CT findings in mikulicz disease and systemic involvement of IgG4-Relatedle-sions[J].Clin Nucl Med,2009,34(3):164-167.
[28] Tomita H,Matsubayashi H,Sasaki K,et al.A case of autoimmune pancreatitis accompanied with Mikulicz’s disease[J].Nihon Shokak-Ibyo Gakkai Zasshi.2010,107(5):775-783.
[29] Tabata R,Tabata C,Okamoto T,et al.Autoimmune pancreatitis as-sociated with myelodysplastic syndrome[J].Int Arch Allergy Im-munol,2010,151(2):168-172.
[30] Fukuhara H,Taniguchi Y,Matsumoto M,et al.IgG4-related tubu-lointerstitial nephritis accompanied with cystic formation[J].BMC Urol,2014,14:54.
[31] Matsubayashi H,Furukawa H,Maeda AA,et al.Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis[J].Pancreatology,2009,9(5):694-699.
[32] 张建,余仲飞,胡胜平,等.18F-FDGPET/CT在自身免疫性膜腺炎诊断及全身评价中的应用.中华胰腺病杂志,2014,14(4):247-251.
[33] Agaimy A,Weyand M,Strecker T.Inflammatory thoracic aortic a-neurysm(lymphoplasmacytic thoracic aortitis):a 13-year-experi-ence at a German Heart Center with emphasis on possible role of IgG4[J].Int J Clin Exp Pathol,2013,6(9):1713-1722.
[34] Holubec T,Laco J,Holubcova z,et al.Repair of thoracic aortic a-neurysm due to noninfectious aortitis[J].J Card Surg,2012,27(2):199-204.
[35] Kamisawa T,Okazaki K,Kawa SA,et al.Japanese consensus guide-lines for management of autoimmune pancreatitis:Ⅲ.Treatment and prognosis of AIP[J].J Gastroenterol,2010,45(5):471-477.
[36] 邓雪蓉,张卓莉.IgG4相关疾病合并淋巴瘤一例[J].中华风湿病学杂志,2014,18(8):574-576,后插1.
[37] Radu CG,Shu CJ,Nair-Gill E,et al.Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new[(18)F]-labeled2,deoxycytidine analog[J].Nat Med,2008,14(7):783-788.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[6]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[7]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[8]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[9]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[10]孙萌萌,付畅,史大鹏,等.不同分期肺腺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2015,39(6):437.[doi:10.3760/cma.j.issn.1673-4114.2015.06.001]
Sun Mengmeng,Fu Chang,Shi Dapeng,et al.Preliminary study of metabolic changes in brain glucose of patients with lung adenocarcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):437.[doi:10.3760/cma.j.issn.1673-4114.2015.06.001]
[11]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[12]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[13]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[14]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[15]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[16]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[17]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[18]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[19]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[20]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]